Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with UpadacitinibOriginal Report Published on 2024-05-062024-09-05 Journal: Acta dermato-venereologica [Category] update2024, [키워드] atopic dermatitis ITCH Janus kinase inhibitor skin clearance Treat-to-target Upadacitinib [DOI] 10.2340/actadv.v104.18452 PMC 바로가기 [Article Type] Original Report
(CGH-D-22-02573) Upadacitinib is Effective and Safe in Both Ulcerative Colitis and Crohn’s Disease: Prospective Real-World ExperienceArticle Published on 2024-04-052024-09-04 Journal: Clinical gastroenterology and hepatology : the off [Category] 대상포진, [키워드] Crohn’s Inflammatory bowel disease Tofacitinib ulcerative colitis Upadacitinib [DOI] 10.1016/j.cgh.2023.03.001 PMC 바로가기 [Article Type] Article
Macrophage re-programming by JAK inhibitors relies on MAFBOriginal Article Published on 2024-03-252024-09-05 Journal: Cellular and Molecular Life Sciences [Category] update2024, [키워드] GM-CSF jak inhibitors macrophage reprogramming macrophages MAFB Monocytes rheumatoid arthritis Upadacitinib [DOI] 10.1007/s00018-024-05196-1 PMC 바로가기 [Article Type] Original Article
Upadacitinib in Crohn’s Disease: A Comprehensive Systematic Review of Efficacy and SafetyGastroenterology Published on 2023-12-172024-09-04 Journal: Cureus [Category] 대상포진, [키워드] Crohn’s disease Efficacy gastroenterology and hepatology Safety systematic review Upadacitinib [DOI] 10.7759/cureus.50657 PMC 바로가기 [Article Type] Gastroenterology
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter studyarticle Published on 2023-10-112024-09-02 Journal: Arthritis Research & Therapy [Category] 대상포진, [키워드] Axial inflammation Bio-refractory Clinical efficacy Minimal disease activity Peripheral arthritis psoriasis psoriatic arthritis real life Safety Upadacitinib [DOI] 10.1186/s13075-023-03182-9 PMC 바로가기 [Article Type] article
Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III studyarticle Published on 2023-09-182024-09-02 Journal: Arthritis Research & Therapy [Category] 대상포진, [키워드] ankylosing spondylitis biologic Inadequate response Janus kinase inhibitor Open-label extension refractory tumor necrosis factor Upadacitinib [DOI] 10.1186/s13075-023-03128-1 PMC 바로가기 [Article Type] article
Oral small molecule agents in management of ulcerative colitis: fact or fancy?Review Article Published on 2023-08-112024-09-04 Journal: Turkish Journal of Medical Sciences [Category] 대상포진, [키워드] Ozanimod sphingosine-1-phosphate receptor modulators Tofacitinib ulcerative colitis Upadacitinib [DOI] 10.55730/1300-0144.5722 PMC 바로가기 [Article Type] Review Article
Impact of upadacitinib on the risk of digestive events in patients with rheumatoid arthritis: A systematic review and meta-analysis of randomized controlled trialsResearch Article Published on 2023-06-042024-09-04 Journal: Heliyon [Category] 대상포진, [키워드] gastrointestinal perforation Hepatic disorder rheumatoid arthritis Upadacitinib [DOI] 10.1016/j.heliyon.2023.e17002 PMC 바로가기 [Article Type] Research Article
Efficacy and safety of abrocitinib and upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: A systematic review and meta-analysisReview Article Published on 2023-06-022024-09-04 Journal: Heliyon [Category] 대상포진, [키워드] abrocitinib Dupilumab Meta-analysis Moderate-to-severe atopic dermatitis Randomized controlled trials Upadacitinib [DOI] 10.1016/j.heliyon.2023.e16704 PMC 바로가기 [Article Type] Review Article
Therapeutic potential of JAK inhibitors in juvenile idiopathic arthritis-associated uveitisArticle Published on 2023-05-032024-09-04 Journal: Expert review of clinical immunology [Category] 대상포진, [키워드] Baricitinib JAK-inhibitor JIA paediatric uveitis Tofacitinib Treatment Upadacitinib Uveitis [DOI] 10.1080/1744666X.2023.2207823 PMC 바로가기 [Article Type] Article